Glp 1 T 2d denied for missing prior authorization by Cigna?

Cigna's specific coverage criteria for glp1 t2d are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied This GLP-1 for Type 2 Diabetes: Prior Authorization Required

Cigna requires prior authorization (PA) for GLP-1 medications used in type 2 diabetes management. This denial means the prescription was processed without an approved PA in place, or that a PA request was submitted but returned incomplete or unresolved. PA is an administrative requirement — it is not a clinical judgment that the medication is inappropriate. The path forward is to file a complete PA request alongside a formal appeal of the denial.

## Why It Is Appealable

Because PA denials are procedural, they are among the most straightforward to resolve when the right documentation is in place. Cigna's PA criteria for GLP-1 agents in type 2 diabetes are published in its medical policies, and your appeal should demonstrate — point by point — that your clinical situation satisfies each criterion. Many PA denials resolve at the peer-to-peer review stage, before a formal written appeal decision is issued.

## Federal Appeal Framework

• Internal appeal (ACA §2719 / ERISA §503): All adverse benefit determinations, including PA denials, are subject to a full and fair internal review. File your written appeal within the timeframe stated on the denial notice.
• Expedited review: If standard review timelines would delay treatment in a way that seriously jeopardizes your glycemic control or health, request expedited internal review. Cigna must respond on an accelerated timeline.
• Peer-to-peer review: Your prescriber should call Cigna's clinical reviewer directly. A peer-to-peer discussion often resolves PA denials more quickly than written appeal and does not waive your formal appeal rights.
• External review: If the internal appeal is denied, independent external review is available under ACA §2719 within approximately four months of the denial notice.

## Documentation to Gather

1. Cigna's PA criteria: Download the current Cigna medical policy or PA criteria document for GLP-1 therapy in type 2 diabetes. This is your definitive checklist. 2. Diagnosis confirmation: Chart notes confirming your type 2 diabetes diagnosis and duration. 3. Prior diabetes treatment history: Dated records of all prior diabetes medications — names, duration of use, and reasons for change or discontinuation — to satisfy any step-therapy or treatment-history requirements in the PA criteria. 4. Current clinical status: Recent lab results and chart notes documenting your current glycemic control and any diabetes-related complications or comorbidities relevant to the PA criteria. 5. Prescriber medical-necessity letter: A structured letter from your prescribing physician addressing each PA criterion individually, with specific chart references. 6. Prescriber availability for peer-to-peer: Confirm your prescriber can respond promptly to a Cigna peer-to-peer request, as timing is often critical.

## Criteria-Mapping Structure

Number each PA criterion from Cigna's policy. In your appeal letter, address each numbered criterion with a one-sentence answer identifying the specific document — exhibit letter, date, and provider — that satisfies it. Attach all exhibits with matching labels. This format is the most reliable way to ensure every criterion is addressed and prevents Cigna from issuing a second denial based on an unaddressed point.